Stay updated on EGFR Mutant Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the EGFR Mutant Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the EGFR Mutant Lung Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:03:26.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update or modification in the study details related to the comparison between Nivolumab alone and Nivolumab in combination with Ipilimumab for patients with advanced EGFR mutation positive Non-small Cell Lung Cancer.
    Difference
    0.1%
    Check dated 2024-06-06T14:27:03.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria,' with additional details on eligibility criteria such as general health condition or prior treatments. The inclusion criteria now specify requirements for informed consent, age, contraception for women of childbearing potential, and other health-related conditions.
    Difference
    53%
    Check dated 2024-05-22T21:15:45.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2024-04-30T22:54:32.000Z thumbnail image

Stay in the know with updates to EGFR Mutant Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the EGFR Mutant Lung Cancer Clinical Trial page.